Esnault V L, Jayne D R, Weetman A P, Lockwood C M
Department of Medicine, School of Clinical Medicine, University of Cambridge, U.K.
Immunology. 1991 Dec;74(4):714-8.
Circulating IgG autoantibodies to myeloperoxidase (MPO) are associated with renal vasculitis and have been implicated in its pathogenesis. However, raised levels of these autoantibodies may persist during clinical remission. We tested whether this paradox could be explained by immunoglobulin subclass switching during disease evolution, since different subclasses have different immunological and biochemical properties. Sera with anti-myeloperoxidase (anti-MPO) activity from 33 patients with active disease and 20 anti-MPO positive follow-up sera were studied by an ELISA using a panel of anti-human IgG subclass monoclonal reagents previously calibrated on human myeloma proteins. Anti-MPO subclass distribution in initial sera was: IgG1, 31 (94%); IgG2, 10 (30%); IgG3, 24 (73%); and IgG4, 22 (67%). IgG3 anti-MPO decreased during follow-up (P less than 0.02), with no change in IgG1 and IgG4. Relative functional affinity of anti-MPO antibodies in purified IgG subclasses was studied by the diethylamine method. IgG3 fractions consistently had a greater affinity for MPO than the other subclasses. Sequential studies in four patients demonstrated an affinity maturation for IgG1 and IgG4 anti-MPO as IgG3 anti-MPO disappeared. We conclude that dynamic changes of subclass distribution and affinity may explain discrepancies between anti-MPO antibody titre and disease expression.
循环中的抗髓过氧化物酶(MPO)IgG自身抗体与肾血管炎相关,并被认为参与了其发病机制。然而,这些自身抗体水平升高在临床缓解期可能持续存在。我们检测了这种矛盾现象是否可以通过疾病演变过程中的免疫球蛋白亚类转换来解释,因为不同亚类具有不同的免疫和生化特性。使用一组先前用人骨髓瘤蛋白校准的抗人IgG亚类单克隆试剂,通过ELISA对33例活动性疾病患者的具有抗髓过氧化物酶(抗MPO)活性的血清和20份抗MPO阳性的随访血清进行了研究。初始血清中抗MPO亚类分布为:IgG1,31例(94%);IgG2,10例(30%);IgG3,24例(73%);IgG4,22例(67%)。随访期间IgG3抗MPO水平下降(P<0.02),IgG1和IgG4无变化。通过二乙胺法研究了纯化的IgG亚类中抗MPO抗体的相对功能亲和力。IgG3组分对MPO的亲和力始终高于其他亚类。对4例患者的连续研究表明,随着IgG3抗MPO消失,IgG1和IgG4抗MPO出现亲和力成熟。我们得出结论,亚类分布和亲和力的动态变化可能解释抗MPO抗体滴度与疾病表现之间的差异。